PACIFIC Study Sets New Standard in Stage III NSCLC Opens Door to Further Progress

PACIFIC Study Sets New Standard in Stage III NSCLC, Opens Door to Further Progress

Scott J. Antonia, MD, PhD, discusses the pivotal data that renewed interest in stage III unresectable non–small cell lung cancer and anticipated data that are expected to advance the field even further.

More From BioPortfolio on "PACIFIC Study Sets New Standard in Stage III NSCLC, Opens Door to Further Progress"